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to develop class II HDAC inhibitors as
therapeutics for treating metabolic disor-
ders. Given that pharmacological HDAC
inhibitors are already in development as
potential anticancer agents, this strategy
seems particularly promising.
Importantly, the two new studies also
raise a number of complex questions
that are critical to understanding the regu-
lation of metabolic homeostasis. First, the
studies highlight the importance of acety-
lation in controlling Foxo function. Given
Foxo’s involvement in numerous physio-
logical processes, this regulatory mecha-
nism is expected to influence not only
metabolism but also cell growth, prolifera-
tion, apoptosis, and longevity. However,
the relative contributions of Sirtuins and
class IIa HDACs for controlling Foxo
activity still remain unknown. It will also
be important to understand why gluco-
neogenic gene expression is regulated
by two distinct pathways: HDAC inhibitionby AMPK/SIK1/2 and CRTC2 inhibition by
SIK1/2. One speculation is that the per-
ceived redundancy allows intricate, con-
text-dependent regulation of gluconeo-
genesis or of Foxo function more
generally. Finally, the physiologic conse-
quences of this regulatory mechanism
might reach beyond glucose and lipid
homeostasis and may include Foxo-
mediated control of life span, cell survival,
and growth. The combined power of
Drosophila and mouse genetics will
clearly provide key insights into these
intriguing questions.REFERENCES
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Bridging a gap between transcriptomics and the study of cis-acting elements (cistromics), Hah et al.
(2011) apply a next-generation sequencing technique to gain an unprecedented view of the
changes in RNA synthesis that occur following estrogen receptor activation in human breast cancer
cells.The regulation of eukaryotic gene expres-
sion is remarkably complex, with the tran-
scriptome in any given cell affected by the
epigenome, which is acted upon by tran-
scription factors binding to cis-acting
elements (the cistrome) and RNA poly-
merases that generate messenger RNAs
(mRNAs) (Figure 1). In this issue, Hah
et al. (2011) bridge transcriptomics and
cistromics to provide surprising insightsinto the genome-wide distribution and
dynamics of transcription in response to
an external stimulus—in this case, the
exposure of human breast cancer cells
to the hormone estrogen.
Techniques based on next-generation
sequencing, most notably chromatin
immunoprecipitation sequencing (ChIP-
seq) andRNA-seq are greatly contributing
to our understanding of transcriptionalregulation. ChIP-seq enables researchers
to localize transcription factor binding or
specific nucleosome structures defining
cistromes in a given cell type or tissue
under different conditions (Lupien and
Brown, 2009). RNA-seq makes it possible
to assay many species of transcripts,
including mRNAs, noncoding RNAs, and
small RNAs, while providing exact infor-
mation about alternative splice variants145, May 13, 2011 ª2011 Elsevier Inc. 499
Figure 1. The Missing Link between the Cistrome and the Tran-
scriptome
Estradiol-bound dimers of the estrogen receptor bind either at distal
enhancers or at promoters of their target genes, thereby defining the estrogen
receptor (ER) cistrome. This binding leads to initiation of transcription by RNA
polymerase 2 (Pol2) and eventually to synthesis of nascent RNA chains. The
steady-state of the cytoplasmic RNA pool—the transcriptome—is determined
by the rate of RNA synthesis divided by the rate of RNA degradation. GRO-seq
(genome-wide nuclear run-on followed by next-generation sequencing)
connects the cistrome and the transcriptome by mapping the quantity and
genome-wide distribution of transcriptionally engagedRNA polymerases. PIC,
preinitiation complex; TSS, transcription start site.in the surveyed biological
sample (Ozsolak and Milos,
2011). Although combining
these approaches is a power-
ful means of gaining biolog-
ical insights, one limitation is
that transcriptomes repre-
sent steady-state mRNA
levels, which are determined
by the rate of mRNA syn-
thesis divided by the rate of
mRNA degradation. RNA
degradation is highly regu-
lated, leading to posttran-
scriptional alteration of gene
expression that is largely
independent of the cistromes
that govern mRNA synthesis.
Thus, to appreciate the true
impact of the cistromes, there
is a need to measure the
synthesis of nascent RNA
molecules and thereby the
numerator of the ‘‘mRNA syn-
thesis/mRNA degradation’’
equation (Figure 1).
Lis and colleagues recently
invented a technique to
address this gap. Called
GRO-Seq (genome-wide nu-
clear run-on followed by
next-generation sequencing)
(Core et al., 2008), it is based
on classical nuclear run-onexperiments in which ongoing transcrip-
tion is studied in isolated nuclei under
conditions that allow labeling of nascent,
actively transcribed RNA molecules,
which can now be purified and deeply
sequenced in a genome-wide manner.
More recently, this lab employed GRO-
seq to compare the distribution of tran-
scriptionally engaged RNA polymerase 2
(Pol 2) in embryonic stem cells and differ-
entiated mouse embryonic fibroblasts
(Min et al., 2011). In another study, GRO-
seq was used to demonstrate that the
male-specific lethal (MSL) complex in
Drosophila enhances transcription by
facilitating the progression of Pol2 across
active X-linked genes, thus contributing to
new understanding of sex-specific gene
dosage differences on X chromosomes
(Larschan et al., 2011). Hah et al. now
utilize GRO-seq to provide exciting new
insights into hormone action.
The authors measure the instantaneous
rate of RNA synthesis in MCF-7 human500 Cell 145, May 13, 2011 ª2011 Elsevier Inbreast cancer cells treated with 17b-
estradiol (E2), a natural ligand of the estro-
gen receptor, for 10, 40, and 160 min.
Using new bioinformatic algorithms for
transcript calling and quantitation, the
authors report numerous insights into
estrogen receptor signaling and tran-
scriptional regulation in general, some of
which relate directly to the difference
between measuring the rate of transcrip-
tion versus the level of mature transcript.
For example, a surprisingly high per-
centage (26%) of transcripts active at
one or more time point during the experi-
ment were regulated by E2 treatment,
whereas 10% respond after only
10 min. In addition, direct comparison of
transcription rate with steady-state tran-
scriptomes (from microarrays) shows
that the synthesis of protein-coding tran-
scripts is transiently responsive to E2
in contrast to the gradual increase in
mRNA levels. Further, the promoters of
most genes that are maximally inducedc.at later time points are first
loaded with Pol2, and only
later does the GRO-seq signal
extend into the gene body.
These insights into the ki-
netics of transcription cannot
be gleaned from measuring
steady-state mRNA levels
that take hours to accumulate.
Moreover, owing to the large
number of nongenic tran-
scripts detected, the GRO-
seq method was able to
assign three to four times
more of the ERa cistrome to
transcribed regions than was
possible using transcriptome
data (Welboren et al., 2009;
Carroll et al., 2006).
GRO-seq also reveals new
aspects of transcription that
cannot be learned by ChIP-
seq for Pol2. Some 16% of the
transcripts stem fromdivergent
transcription, a phenomenon
that has recently been shown
to be widespread in the ge-
nome and may promote a
nucleosome-poor environment
at promoters where transcrip-
tional rates need to be high
(Seila et al., 2009). Consistent
with this, E2 regulates hun-
dreds of divergent transcriptsthat correlate with accumulation of the
protein-coding mRNA. In addition, Hah
et al. uncover antisense transcription and
transcripts from Pol1 and Pol3—some
regulated by E2—that cannot be identified
by Pol2 ChIP-seq because it does not
deliver strand-specific information.
The authors also noted short pieces of
RNA transcribed from enhancers, as was
recently observed in neurons using RNA-
seq and Pol 2 ChIP-seq (Kim et al., 2010).
The observation of RNAs emanating from
enhancers using different methods in very
different cell systems suggests their
general existence. Although their function
remains obscure, their locations are
consistent with the finding of ER and other
transcription factors at enhancers far from
transcription start sites (the ‘‘dark matter’’
of the genome) that has been one of the
major surprises of cistromics.
It is clear that transcriptome analyses,
especially RNA-seq, will continue to pro-
vide valuable biological information. Logic
suggests that steady-state protein levels,
which largely determine cellular functions,
will correlate better with steady-state
mRNA levels than with the rate of mRNA
transcription, although this should be
formally proven. But for those interested
in the direct effects of transcription fac-
tors or of the environment (including
hormonal signals) upon transcription, the
ability to measure the rates of RNA
synthesis in a genome-wide manner—
the ‘‘RNA synthesome’’—opens new
doors to discovery.
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